Atomwise
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
| Company Details | |
|---|---|
| Title | Atomwise |
| Industries | Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Pharmaceutical |
| Headquarters Regions | San Francisco Bay Area, West Coast, Western US |
| Headquarters Location | San Francisco, California, United States |
| No Of Employees | 101-250 |
| Operating Status | Active |
Description
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn.